● Xi'an Tianlong Technology Co., Ltd. was established.
● Xi'an Tianlong became the first batch of medical equipment (class III) production enterprises.
● Hold the National Science and Technology High Technology Research and Development Program (863 Program): Major Disease Detection and Early Warning Micro System - Portable Molecular Diagnostic Residualization Detector.
● Compese with Xi'an Jiaotong University, built Shaanxi Provincial Life Science Detection Instrument Engineering Technology Research Center (dependent unit).
● Established Suzhou Tianlong Biotechnology Co., Ltd.
● The fluorescent quantitative PCR instrument is equipped with the National Influenza Monitoring Network Laboratory, and the first case of H1N 1 in Shaanxi Province has been detected and has been confirmed by several thousand cases in China, which contributed to the prevention and control of public health.
● Get investment in SK multinational groups of 57-bit SK multinational groups in the world.
● National Major Scientific Instrument Equipment Equipment, Hosting in April: Nucleic Acid Automation Quantitative Detection and High Resolution Analysis Equipment Development and Its Application.
● Xi'an and Suzhou Tianlong Company have a new address.
● Established a third-party independent medical laboratory - Xi'an Tianbo Medical Inspection Institute, providing \"product + service overall solutions based on customer needs.\"
● Investment Holdings Wuxi Ruiqi Genetic Biotechnology Co., Ltd. Opens the new era of individualized medication.
● Tianlong Technology Intelligent Medical Equipment R & D and Production Project, Independent Medical Experiment Equipment and Reason Production Project and Medical Health Industrial Park officially laid the foundation.
● Gain strategic investment in Shanghai Bihua Biological Engineering Co., Ltd. (Stock Code: 002022).
Tianlong Technology is based on market-oriented, and has been based on the research and development of science and technology, and pursues independent brands.